120 results
S-4/A
EX-10.22
KA
Kineta Inc
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
, Company’s benefit plans and fringe benefits may be amended by Company from time to time in its sole discretion.
(f) Reimbursement of Expenses. Company … in accordance with Company’s policies with respect thereto as in effect from time to time. Executive must submit any request for reimbursement no later
S-4/A
EX-10.24
KA
Kineta Inc
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement or advancement … as to such claim, issue or matter.
Section 6. Reimbursement for Expenses of a Witness or in Response to a Subpoena. Notwithstanding any other provision
8-K
EX-10.6
KA
Kineta Inc
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement or advancement … , issue or matter.
Section 6. Reimbursement for Expenses of a Witness or in Response to a Subpoena. Notwithstanding any other provision
8-K
EX-99.5
gdccdf6k52qp yklm6t
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K/A
EX-99.1
afhsne8
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
3d9ym41jit0qpagoa8
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
d4wf76u335wcv
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
10-Q
9hpmdv
13 May 16
Quarterly report
12:00am